Other Briefings
Cell and Gene Therapy Manufacturing in Singapore: An Investor’s Operating Thesis
Explore investment pathways in Singapore’s cell and gene therapy sector, from facilities to CDMOs, with tax and regulatory insights.
M&A Through Singapore: Share Vs Asset Deals and Stamp Duty
Foreign investors must weigh share vs asset deals in Singapore M&A, considering stamp duty, GST, liabilities, and exit strategy.
Tax Incentive Requirements for Family Offices in Singapore: What’s New in 2025
We demonstrate the key requirements to qualifying for income tax exemption for family offices in Singapore.
Why Singapore Is the Legal and Operational Hub for ASEAN M&A
Singapore’s legal predictability, tax-and-treaty framework, deep financing pools, and reliable dispute resolution make it the control hub for ASEAN M&A.
Transfer Pricing in Singapore: Compliance and Strategy for Foreign Investors
Ensure compliance with Singapore’s transfer pricing rules while optimizing tax outcomes and protecting cross-border profits.
Singapore’s New Medical Insurance Rules for Foreign Workers Are Now in Effect
Singapore’s new insurance rules for foreign workers took effect July 1, 2025. Learn how premiums and coverage have changed.
Singapore Backs Timor-Leste’s ASEAN Entry with eSTARS
Singapore launches enhanced eSTARS package to support Timor-Leste’s ASEAN membership and boost regional integration efforts.
Singapore to Roll Out Business Adaptation Grant in October
Singapore will roll out a Business Adaptation Grant in October 2025 to help firms manage US tariffs and restructure supply chains.
An Introduction to Doing Business in Singapore 2025 – New Publication from Dezan Shira & Associates
An Introduction to Doing Business in Singapore 2025 covers market entry, tax, HR & payroll, and audit & compliance considerations.
Islamic Finance in Singapore: Unlocking Growth Potential in a Strategic Financial Hub
Explore Singapore’s Islamic finance growth, sukuk listings, fintech, and its role as a regional hub for Shariah-compliant investment.
